HemaCell
PrivateLast Round
Series B
Jun 2, 2026
Total Funding Raised
$57.3M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
HemaCell operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was a Series B round in June 2026.
HemaCell is a biotechnology company that develops stem cell-based therapeutics for the regeneration of blood cells to treat various diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HemaCell Comparables
Compare HemaCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HemostOD SA | 83% | |
| Megakaryon Corporation | 80% | |
| Stellular Bio | 77% |
For institutional investors. Book with your work email.
HemaCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 2, 2026 | ||||
| VC Round | Jan 8, 2025 | ||||
| Series A | Dec 19, 2023 | ||||
| VC Round | May 27, 2022 | ||||
| Pre Seed | Feb 25, 2022 | ||||
Seed | Oct 9, 2021 |
For institutional investors. Book with your work email.
HemaCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongbo Juli | Series A |
| 招银国际金融有限公司 | Pre Seed |
| Wedo Venture Partners | Series B, Pre Seed, VC Round, Seed |
| Northern Light Venture Capital | Pre Seed, VC Round |
| Country Garden Ventures Capital | Pre Seed, VC Round |
| Luxin Venture Capital Group | VC Round |
| Founder Hesheng Investment Co., Ltd. | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2026
$42M round with CDH Investments and others
- Jan 8, 2025
Completed a VC Round fundraise.
For institutional investors. Book with your work email.
HemaCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HemaCell's valuation, stock price, and market status.
Is HemaCell a public or private company?
HemaCell is a private company.
What is the current stock price of HemaCell?
HemaCell is a private company, so its shares have no public market price. Caplight tracks HemaCell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HemaCell worth (valuation)?
Valuation information for HemaCell is not publicly available.
Can I buy HemaCell stock?
HemaCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HemaCell's last funding round?
HemaCell's most recent funding round was Series B on June 2, 2026.
Who are the main investors in HemaCell?
Key investors in HemaCell include Zhongbo Juli, 招银国际金融有限公司, Wedo Venture Partners.
Will HemaCell IPO soon?
No public IPO plans have been announced for HemaCell.
How can I track HemaCell secondary market activity?
Caplight tracks bids, offers, and trades in HemaCell's shares on secondary markets.